CO168 A Propensity Score-Based Comparison of Tepotinib Versus Immunotherapy with/without Chemotherapy, Using Real-World Data in Previously Untreated Met Exon 14 (METEX14) Skipping Non-Small Cell Lung Cancer (NSCLC)

E Hook, R Batteson + Show 5 more

https://doi.org/10.1016/j.jval.2023.09.240

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Publication Date: Dec 1, 2023

Affiliation: University Hospital Heidelberg

#MET Exon 14 #Non-Small Cell Lung Cancer + Show 2 more

Abstract
Full-Text PDF
Similar Papers

Abstract

CO168 A Propensity Score-Based Comparison of Tepotinib Versus Immunotherapy with/without Chemotherapy, Using Real-World Data in Previously Untreated Met Exon 14 (METEX14) Skipping Non-Small Cell Lung Cancer (NSCLC)

Full Text

Published version (

Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title

Journal

Date

Author

View more papers

Translate this paper in your preferred language
Listen to the abstract of this paper

Save
Share
Export